Stock BGBIO BERGENBIO ASA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BerGenBio ASA

Equities

BGBIO

NO0010650013

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-24 am EDT 		5-day change 1st Jan Change
0.165 NOK +5.10% Intraday chart for BerGenBio ASA +1.73% -40.65%
Mar. 20 Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation CI
Feb. 14 BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on BerGenBio ASA

Price target over the last 5 years

History of analyst recommendation changes

ffea4d6735.6YT946ygX4Dvrr2riHq6x981MmfRdPN3pTST6wkHxnw.iuOohprLNLKV_Ijy2yqOkux6SwWBQKQt13bpvkxA9gnb0M3O5PYxt57-2g~5ad85259150bb4383f94226f64a9578b

Analyst Recommendations on BerGenBio ASA

BerGenBio Reports 43% Response Rate With Bemcentinib Monotherapy in AXL Positive R/R AML/MDS Patients at ASH CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.165 NOK
Average target price
0.7667 NOK
Spread / Average Target
+364.65%
High Price Target
2 NOK
Spread / Highest target
+1,112.12%
Low Price Target
0.05 NOK
Spread / Lowest Target
-69.70%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BGBIO Stock
  4. Consensus BerGenBio ASA